跳至主要内容
临床试验/NCT01846312
NCT01846312已完成不适用

The Longitudinal Diabetes Biomarker Study: An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Fluctuation in islet autoantibodies titers

研究概览

简要总结

This study is conducted in the United States of America (USA). The aim of the study is to assess longitudinal variation of immune biomarkers in subjects at risk for development of type 1 diabetes (T1D).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
4 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with general good health as judged by the investigator
  • Participant tested positive at above or equal to 99th percentile for one or more of three islet antibodies (GAD (glutamic acid decarboxylase), IA2 (islet antigen-2), IAA (insulin autoantibody))

排除标准

  • Any chronic disorder (diabetes at enrolment) or severe disease which, in the opinion of the investigator, might jeopardize subject's safety or compliance with the protocol
  • Female of child-bearing potential who is pregnant, breast-feeding, or intends to become pregnant

结局指标

主要结局

Fluctuation in islet autoantibodies titers

时间窗: One-two years dependent on sampling frequency

次要结局

  • Fluctuation in islet autoantibody isotypes(One-two years dependent on sampling frequency)
  • Fluctuation in T-cell specificity profiling (mainly for CD8 (cluster of differentiation 8) T-cells)(One-two years dependent on sampling frequency)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

An Observational Study to Assess Longitudinal... | 临床试验